Gareth S. Dulai

Gareth S. Dulai

Auto-generated profile, based on publicly available information

Gareth S. Dulai

UCLA Digestive Disease Center

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2004 in Endoscopy
Verified
Journal Article
Closed access
PDF file
GDG. S. Dulai
G. S. Dulai
DJD. M. Jensen
D. M. Jensen
TKT. O. G. Kovacs
T. O. G. Kovacs
IGI. M. Gralnek
I. M. Gralnek
RJR. Jutabha
R. Jutabha
Background and Study Aims: Watermelon stomach is a source of recurrent gastrointestinal hemorrhage and anemia. The aims of this study were to describe the endoscopic appearance and treatment outcomes in watermelon stomach patients with and without portal hypertension. Patients and Methods: All patients with watermelon stomach enrolled in a hemostasis research group’s prospective studies from 1991 to 1999 were identified. Investigators collected data using standardized forms. Comparisons were made using the chi-squared test, Wilcoxon rank-sum test, and Wilcoxon signed-rank test. Results: Twenty-six of 744 (4 %) consecutively enrolled patients with nonvariceal upper gastrointestinal hemorrhage had watermelon stomach as the cause. Eight of these 26 patients (31 %) also had portal hypertension. These patients had diffuse antral angiomas, as opposed to the classic linear arrays seen in those without portal hypertension. The demographic data and clinical presentations of the two groups were otherwise similar. Palliative endoscopic treatment was associated with a significant rise in hematocrit and a decrease in the need for blood transfusion or hospitalization in watermelon stomach patients with and without portal hypertension. Conclusions: Watermelon stomach patients with and without portal hypertension had similar clinical presentations. The endoscopic findings differed in that those with portal hypertension had more diffuse gastric angiomas. Bleeding was effectively palliated by endoscopic treatment, regardless of the presence of portal hypertension.

22 March 2004 in Cancer
Verified
Journal Article
Open access
PDF file
GDGareth S. Dulai
Gareth S. Dulai
MFMelissa M. Farmer
Melissa M. Farmer
PGPatricia A. Ganz
Patricia A. Ganz
CBCoen A. Bernaards
Coen A. Bernaards
KQKaren Qi
Karen Qi
KKKatherine L. Kahn
Katherine L. Kahn
BACKGROUND: Colorectal cancer (CRC) screening tests (e.g., fecal occult blood testing [FOBT], flexible sigmoidoscopy [FS], etc.) are underused. Primary care providers (PCPs) play a critical role in screening, but barriers to and facilitators of screening as perceived by PCPs in managed care settings are poorly understood. The objectives of the current study were to describe current CRC screening practices and to explore determinants of test use by PCPs in a managed care setting.METHODS: In 2000, a self‐administered survey was mailed to a stratified, random sample of 1340 PCPs in a large, network model health maintenance organization in California.RESULTS: The survey response rate was 67%. PCPs indicated that 79% of their standard‐risk patients were screened for CRC. PCP‐reported median rates of recommendation for the use of specific screening tests were 90% for FOBT and 70% for FS. In logistic regression models, perceived barriers to the use of FOBT and FS included patient characteristics (e.g., education) and PCP‐related barriers (e.g., failure to recall that patients were due for testing). Perceived facilitators of the use of FOBT and FS included interventions targeting certain aspects of the health care system (e.g., reimbursement) and interventions targeting certain aspects of the tests themselves (e.g., provision of evidence of a test's effectiveness). Assignment of high priority to screening, integrated medical group (as opposed to independent practice association) affiliation, and the proportion of patients receiving routine health maintenance examinations were positively associated with reported test use.CONCLUSIONS: CRC screening tests appear to be underused in the managed care setting examined in the current study. The perceived barriers and facilitators that were identified can be used to guide interventions aimed at increasing recommendations for, as well as actual performance of, CRC screening. Cancer 2004. © 2004 American Cancer Society.

1 April 2006 in Current Treatment Options in Gastroenterology
Verified
Journal Article
Closed access
PDF file
GDGareth S. Dulai
Gareth S. Dulai
DJDennis M. Jensen
Dennis M. Jensen

1 March 2002 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
GDGareth S. Dulai
Gareth S. Dulai

1 January 2004 in Gastrointestinal Endoscopy Clinics of North America
Verified
Journal Article
Closed access
GDGareth S Dulai
Gareth S Dulai
DJDennis M Jensen
Dennis M Jensen

1 April 2012 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
DJDennis Michael Jensen
Dennis Michael Jensen
GOGordon V. Ohning
Gordon V. Ohning
TKThomas O. Kovacs
Thomas O. Kovacs
RJRome Jutabha
Rome Jutabha
KGKevin Ghassemi
Kevin Ghassemi
GDGareth S. Dulai
Gareth S. Dulai